Prognostic Impact of miR-224 and RAS Mutations in Medullary Thyroid Carcinoma

Elisabetta Cavedon, Susi Barollo, Loris Bertazza, Gianmaria Pennelli, Francesca Galuppini, Sara Watutantrige-Fernando, Simona Censi, Maurizio Iacobone, Clara Benna, Federica Vianello, Stefania Zovato, Davide Nacamulli, Caterina Mian

Research output: Contribution to journalArticle

Abstract

Little is known about the function of microRNA-224 (miR-224) in medullary thyroid cancer (MTC). This study investigated the role of miR-224 expression in MTC and correlated it with mutation status in sporadic MTCs. A consecutive series of 134 MTCs were considered. Patients had a sporadic form in 80% of cases (107/134). In this group, REarranged during transfection (RET) and rat sarcoma (RAS) mutation status were assessed by direct sequencing in the tumor tissues. Quantitative real-time polymerase chain reaction was used to quantify mature hsa-miR-224 in tumor tissue.RAS(10/107 cases, 9%) andRET(39/107 cases, 36%) mutations were mutually exclusive in sporadic cases. miR-224 expression was significantly downregulated in patients with the following: high calcitonin levels at diagnosis (p= 0.03,r= -0.3); advanced stage (p= 0.001); persistent disease (p= 0.001); progressive disease (p= 0.002); and disease-related death (p= 0.0001). We found a significant positive correlation between miR-224 expression and somaticRASmutations (p= 0.007). Patients whose MTCs had a low miR-224 expression tended to have a shorter overall survival (log-rank testp= 0.005). On multivariate analysis, miR-224 represented an independent prognostic marker. Our data indicate that miR-224 is upregulated inRAS-mutated MTCs and in patients with a better prognosis and could represent an independent prognostic marker in MTC patients.

Original languageEnglish
Pages (from-to)4915736
JournalInternational Journal of Endocrinology
Volume2017
DOIs
Publication statusPublished - 2017

Keywords

  • Journal Article

Fingerprint Dive into the research topics of 'Prognostic Impact of miR-224 and RAS Mutations in Medullary Thyroid Carcinoma'. Together they form a unique fingerprint.

  • Cite this

    Cavedon, E., Barollo, S., Bertazza, L., Pennelli, G., Galuppini, F., Watutantrige-Fernando, S., Censi, S., Iacobone, M., Benna, C., Vianello, F., Zovato, S., Nacamulli, D., & Mian, C. (2017). Prognostic Impact of miR-224 and RAS Mutations in Medullary Thyroid Carcinoma. International Journal of Endocrinology, 2017, 4915736. https://doi.org/10.1155/2017/4915736